Objective: To evaluate diffusion-weighted whole-body MRI with background body signal suppression (DWIBS) at 3.0 T for pulmonary lesion detection and characterization. Materials and Methods: 19 patients with 25 pulmonary lesions were examined with DWIBS using 2 b-values (b = 0 and 1000 s/mm²) and partly additionally with DWIBS using 3 b-values (b = 0, 50, 1000 s/mm²). DWIBS was compared to FDG PET. For characterization of hyperintense lesions by DWIBS, Lesion-to-Spinal cord Ratio (LSR) and apparent diffusion coefficient ADC were analyzed. From repeated measurements, the Coefficient of Variation (CV) was calculated. From 3-b-value data, the ADC(0,1000) and ADC(50,1000) values were compared in order to assess perfusion influences. Results: Sensitivity and specificity of detecting malignant lesions were comparable for DWIBS and FDG PET. Malignant compared to benign lesions had lower ADC(0,1000) and higher LSR values. CV of LSR was more than a factor of 8 higher than CV of ADC(0,1000) (23.9% vs 2.9%, P = 0.012). Perfusion effects were largest for metastases, medium for adenocarcinoma and benign lesions, and lowest for squamous cell carcinoma. Conclusion: DWIBS at 3.0 T is appropriate for lesion detection and characterization. ADC analysis is superior to signal intensity ratio determination with respect to repeatability. An analysis of perfusion influences provides additional information. 
Introduction
Standard imaging techniques provide a high sensitivity for detection of pulmonary lesions however specificity is limited [1] . Diagnostic accuracy can be improved by using functional techniques such as Dynamic Contrast Enhanced (DCE) CT, 18 F-labeled 2-Fluoro-2-Deoxy-D-Glucose (FDG) Positron Emission Tomography (PET), 99m Tc-depreotide Single Photon Emission Computed Tomography (SPECT), DCE MRI, and Diffusion-Weighted Imaging (DWI) [2] . DWI is a noninvasive, radiation-and contrast agentfree MRI method, which detects the microscopic motion of water molecules within a voxel, providing information on the biophysical properties of tissue, such as cell organization, cell density, microstructure, and microcirculation [3] . With recent ad-vancements, technological challenges of chest DWI have at least partially been solved [3, 4] . In comparison to DCE CT, DCE MRI, FDG PET and SPECT, with DWI lower sensitivity but higher specificity for differentiation of malignant from benign lung lesions was found [2, 5] . Recent studies even found higher sensitivity and equal specificity for DWI compared to FDG PET [6, 7] . The detection rate of DWI for tumor recurrence and metastasis was similar to PET/CT [8] . As an adjunct to DCE MRI, DWI can improve the diagnostic accuracy of DCE MRI [9] . A general problem of chest DWI is that image quality is limited by susceptibility-induced artefacts at air-tissue and bone-soft tissue interfaces and by motion artefacts due to breathing, heartbeat and vascular pulsation [3] . Most studies were performed at 1.5 T [3, 5, 7, 8, 10, 11] . In conventional DWI spectral selective fat suppression methods were used, which are sensitive 2 to magnetic field inhomogeneity. For the chest, a more robust DWI technique is provided by diffusion-weighted whole body imaging with background body signal suppression (DWIBS) [3] as introduced by Takahara et al [12] . DWIBS is acquired during free breathing and using Short TI Inversion Recovery (STIR) fat suppression. Although offering less Signal-to-Noise Ratios (SNR) in comparison to conventional DWI, DWIBS has proven to be less prone to magnetic field inhomogeneity and therefore more suitable for imaging of the lungs.
Higher field strengths offer increased SNR. However, technological challenges with respect to artefacts, radio frequency inhomogeneity, and fat suppression, are even higher at 3.0 T compared to 1.5 T [13, 14] . Up to now, only little experience exists for chest DWI at 3.0 T [3, [15] [16] [17] [18] , especially for the DWIBS variant [9, 13, 14, 19] . However, there is growing interest, especially due to the increased clinical use of combined FDG-PET/MRI scanners working at 3.0 T [20] . Therefore, the aim of this study was to evaluate DWIBS at 3.0 T for pulmonary lesion detection and characterization.
Materials and methods

Patient Population
The study was approved by the local institutional review board, and written informed consent was obtained from all patients. 19 consecutive patients (12 male, 7 female; mean age: 65 years; age range: 27 -79 years) with 25 pulmonary lesions suspected of being primary lung cancers at chest CT were included. In order to avoid partial volume effects, only lesions with a size larger than 10 mm were included. The final diagnosis was lung cancer in 14 lesions (8 adenocarcinomas, 4 squamous cell carcinomas, 1 small cell carcinoma, and 1 large cell carcinoma), five metastases, and six benign lesions (2 chronic fibrotic inflammation, 3 active pneumonia and 1 schwannoma). Histopathological diagnoses were obtained after lung biopsy or surgical resection in all lung carcinomas and in four benign pulmonary lesions. The five pulmonary metastases with histologically confirmed primary tumors were initially detected by CT (n = 3) and PET/CT (n = 2) and confirmed by follow-up examination (after an average time of 4.6 months). Two pulmonary lesions were diagnosed as inflammatory consolidations because size was regressive on CT and x-ray during a 3-month follow-up examination. None of the 25 lesions had apparent cavitation and calcification on CT images. All lesions had a size larger than 12 mm. The mean size (± standard deviation) of the lesions was 47 ± 22 mm (range from 12 to 82 mm) for the malignant cases and 41 ± 42 mm (range from 16 to 125 mm) for the benign cases, with the long axis diameter of the pulmonary lesions determined on CT images.
All lesions with exception of one (schwannoma) were examined by integrated PET/CT (n = 24). DWI and PET/CT imaging were performed within a 2-week interval. For organizational reasons, in five patients MRI and PET/CT could not be performed until the first, respectively the second cycle of chemotherapy (n = 4 adenocarcinoma, n = 1 squamous cell carcinoma, n = 3 metastases).
MR Protocol
All examinations were performed on a clinical 3.0-T whole-body MRI system (Achieva 3.0T TX; Philips Healthcare, Abbreviations: RL -right-left direction, AP -anterior-posterior direction, FH -feet-head direction, EPI -echo-planar imaging, TE -echo time, TR -repetition time, SENSE -parallel imaging with sensitivity encoding, STIR -short TI inversion recovery, TI -inversion time, WFS -water fat shift, BW -band width, SSGR -slice-selective gradient reversal.
PET/CT
PET/CT was performed using a Somatom Emotion Duo scanner (Siemens, Erlangen, Germany). CT slices and PET emission data were acquired from the skull to the mid-thigh. All patients fasted for at least 8 hours prior to FDG injection. Serum glucose levels did not exceed 160 mg/dl in any patient. Image acquisition started 60 min after intravenous injection of 370 to 550MBq of FDG. CT scan was performed after intravenous injection of contrast medium (Ultravist 300 ® , Bayer Healthcare, Leverkusen, Germany). To achieve a parenchymal contrast, a bolus of 80 ml was injected with a flow of 2 ml/s and the scan was started with a delay of 60 s. CT was acquired with the following parameters: 130 kV, 160 mAs, slice thickness 5 mm, increment 4.25 mm, pitch 1.5, rotation time 0.5 s. The PET acquisition was started immediately after CT imaging. Acquisition time was 4.5 min per bed position (5 -8 bed positions per patient). Each position had 35 scanning planes with a 14.6 cm longitudinal field of view and a 1-slice overlap between scanning positions. CT and PET images were matched and fused into axial images of 4.25 mm thickness.
Qualitative Analysis of DWIBS and PET/CT Images
The sensitivity and specificity of detecting malignant lesions was investigated for DWIBS and FDG PET images. Hereby, the patient with the schwannoma was not included, because no PET/CT was available. Histological results served as gold standard. The qualitative analysis of FDG PET images was performed by one board-certified specialist for nuclear medicine together with a board-certified radiologist. The reader was unaware of the patients' clinical data. All suspected pulmonary and mediastinal lesions were identified on the PET/CT images and then visually judged on the FDG PET images with respect to their FDG-uptake. DWIBS images were evaluated qualitatively by 2 board-certified radiologists with 13 and 6 years of clinical MRI experience and one physicist with more than 16 years of experience in DWI. The readers were unaware of the patients' clinical data. The suspected lesions on CT images were identified on the diffusion-weighted b = 1000 s/mm 2 images with respect to hyperintensity.
Quantitative Analysis of DWIBS Images
All hyperintense lesions on b = 1000 s/mm 2 images were quantitatively analysed by ADC and lesion-to-spinal cord ratio (LSR) determination by the same readers as before. An elliptic or a freehand-drawn region of interest (ROI), as large as possible, was carefully placed on the DWI b = 1000 s/mm 2 image by adapting the ROI to the most hyperintense structures (lowest ADC values) in order to better characterize malignancy in case of heterogeneity [21] or obstructive consolidation [11, 22] . We excluded necrotic areas, areas close to the lesion rim to avoid partial-volume effects, and areas with obvious motion or susceptibility artefacts. After visually cross-checking for pixel misalignments between images with different b values, the ROI was copied into the ADC parameter map. For the repeated measurements, the same shape and size of the ROIs were used, but ROIs were adapted to the actual lesion position. For LRS analysis, the mean signal intensity within the chosen ROI and within the spinal cord was analyzed on the same b = 1000 s/mm 2 image. The ADC(0,1000) and LSR values of the two b-value data sets were analyzed with respect to differences between malignant and benign lesions and between histological subgroups. These analyses were performed twice, once with the whole data set and once with reduced data set where treated lesions were excluded in order to avoid ADC confounding/blurring induced by therapy.
From repeated data, an intra-subject coefficient of variation (CV) of ADC(0,1000) and LSR values was determined, whereby CV was calculated as the standard deviation of the parameters belonging to the two measurements divided by the mean of the measured values. At last, the three b-value data sets were analyzed with respect to differences between the ADC(0,1000) and ADC(50, 1000) values. This analysis was performed twice, once with the whole data set and once with reduced data set where treated lesions were excluded.
Statistical Analysis
The results of visual judgment were analyzed using a binary classification test. Statistical significance (P < 0.05) of differences between two groups was tested using the Mann-Whitney U test in case of independent samples and Wilcoxon signedrank test in case of paired samples. For analysis of multiple independent subgroups the Kruskal-Wallis test was performed. Statistics were performed in SPSS (version 21.0, IBM, Armonk, NY, USA).
Results
Qualitative Analysis of DWIBS and PET/CT Images
All malignant lesions (n = 19) appeared hyperintense on b = 1000 s/mm² images and also on FDG PET images. Among the benign lesions, 40% (2 of 5 lesions) appeared hyperintense on DWIBS (1 chronic fibrotic lesion, 1 active pneumonia) and 60% (3 of 5 lesions) on PET (2 chronic fibrotic lesions, 1 active pneumonia) (see Table 2 ). An example is given in Figure 1 . 
Quantitative Analysis of DWIBS Images
The ROI sizes (mean ± standard deviation) of analyzed lesions were 92 ± 124 mm 2 (range: 10 -496 mm 2 ) and of spinal cord 17 ± 10 mm 2 (range: 8 -39 mm 2 ). The results of ADC(0,1000) and LSR value analysis are summarized in Table 3 . An example is given in Figure 2 . For the malignant lesion group compared to the benign lesion group, lower ADC(0,1000) values and higher LSR values were found (1074 ± 204 vs 1171 ± 260 and 2.34 ± 0.96 vs 1.79 ± 0.30, respectively, when treated lesions are excluded), however, the differences were not statistically significant, neither for the whole data set nor for the reduced data set of untreated lesions. Despite the low case numbers, a subgroup analysis was attempted between histopathological subgroups of malignant lesion, but unfortunately no significant differences were found. By tendency, smaller ADC(0,1000) values were found for squamous cell carcinoma compared to adenocarcinomas (855 ± 26 vs 1237 ± 169, P = 0.095). For LSR values neither a significant difference nor a general trend was observed. Table 3 : Apparent diffusion coefficient ADC(0,1000) and lesion-to-spinal cord ratio (LSR) for the different histopathology types of lung carcinomas, metastases, and benign lesions (only those with hyper intensity on b = 1000 s/mm 2 image). Mean values ± inter individual standard deviations are given for each subgroup. For subgroups including treated lesions, the data without those lesions were also listed (after forward slash). Results of statistical comparisons for groups with n ≥ 3 are given. For P > 0.100 the abbreviation ns for not significant was used, for 0.5 ≤ P ≤ 0.100 values were given in round brackets indicating that the values are different by tendency. The comparison between data of the first and repeated measurement (whole data set) did not reveal any significant differences, neither for ADC(0,1000) nor for LSR values. The mean intra-individual coefficient of variation (CV) of ADC(0,1000) values was 2.9% and of LSR values 23.9%, which is more than a factor of 8 higher. This difference was statistically significant (P = 0.012). The ADC(0,1000) given in mm 2 /s of the adenocarcinoma is higher than that in the solid part of the schwannoma (997 ± 105) and lower than of the pneumonia (1423 ± 200). The lesion-to-spinal cord ratio (LSR) of the adenocarcinoma (1.60) is higher than in the schwannoma (1.18) and lower than in the pneumonia (2.05). The coefficients of variations of the ADC(0,1000) values were lower (1.7% for the adenocarcinoma and 10.4% for the schwannoma) than for the LSR (12.4% for the adenocarcinoma, 33.3% for the schwannoma). For pneumonia no 3-b-value sequence was acquired. Differences between ADC(0,1000) and ADC(50,1000) were 10.1% in the adenocarcinoma and 8.0% in the schwannoma. Table 4 : Apparent diffusion coefficients ADC(0,1000) and ADC(50,1000) as well as relative differences between them (rel. diff.) obtained from the three b-value sequence for the different histopathology types of lung carcinomas, metastases, and benign lesions (only those with hyper intensity on b = 1000 s/mm 2 image). Mean values ± inter individual standard deviations are given for each subgroup. For subgroups including treated lesions, the data without those lesions were also listed (after forward slash). 
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The ADC(0,1000) and ADC(50, 1000) values obtained from the three b-value sequence are summarized in Table 4 . Including all data, the ADC(50, 1000) values were significantly lower than the ADC(0,1000) values (1020 ± 228 compared to 1111 ± 244, P = 0.016). This was also found by tendency for the reduced data set of untreated lesions (1043 ± 216 compared to 1140 ± 217, P = 0.063). The mean difference between ADC(0,1000) and ADC(50, 1000) values was largest for the metastases (27.3%), medium for adenocarcinoma and benign lesions (7.8% and 8.0%, respectively), and lowest for squamous cell carcinoma (< 0.1%).
Discussion
The aim of this work was to gain more experience with DWIBS at 3.0 T for pulmonary lesion detection and characterization. The lesion detectability of DWIBS was comparable with FDG PET. Concerning lesion characterization, quantitative analysis of apparent diffusion coefficient ADC(0,1000) was superior to lesion-to-spinal cord ratio LSR with respect of repeatability. The use of 3 instead of 2 b-values enabled additional information about perfusion influences. The acquisition technique was "state of the art" with dual-source RF transmission technology, parallel imaging with sensitivity encoding (SENSE), and advanced fat suppression methods. The sequence was optimized for the equipment previously [13, 14] . The rough comparison between DWIBS and FDG PET imaging revealed very high sensitivity of detecting malignant lesions (100%) for both modalities. The specificity was worse with 40% false positive results in case of DWIBS and 60% for FDG PET. The results of this study are in general agreement with previous studies. However, results may depend on group compositions. In our study, no bronchioloalveolar cancers or mucinous adenocarcinomas were included. In other studies, false negative results in FDG PET studies occurred in bronchioloalveolar cancers, whereas DWI failed in case of mucinous adenocarcinomas [7] or if lesions were affected by cardiac motion [23] . Moreover, in our study, the benign lesion group contained active pneumonia and chronic fibrotic inflammation, which were partly detected as false-positive. For the active pneumonia the number of false positive results was the same for both modalities, whereas for chronic fibrotic inflammation more false positive results were detected by FDG PET. In other studies, a similar or higher number of active inflammatory lesions and chronic inflammation were detected as false-positive by FDG PET compared to DWI [6, 7, 16, 20, 21, 24] . The sensitivity reported in other studies was found to be similar or superior for conventional DWI compared to FDG PET [6, 7, 16, 21, 24] , with exception of one study reporting inferior sensitivity [23] . The specificity was found to be comparable between FDG PET and conventional DWI at 1.5 and 3.0 T and DWIBS at 1.5 T [6, 7, 16, 24] , with exception of one study reporting superior specificity for DWI [21] . As both diagnostic modalities have their specific strengths and weaknesses [7, 16] , the combined use of DWI and FDG PET using PET MRI scanners, may provide beneficial with respect to diagnostic accuracy [20, 21] . For lesion characterization with DWI, different methods have beans used: e.g. visual inspection of signal intensity in comparison to muscle or spinal cord, semiquantitative analysis of lesion-to-spinal cord signal intensity ratio (LSR), or quantitative determination of the apparent diffusion coefficient (ADC) [3, 4, 7, 21, [25] [26] [27] . At 1.5 T, it remained unclear which analysis method should be preferred [4, 26, 27] . For 3.0 T up to now no comparative study exists. In our study, malignant lesions had by tendency lower ADC(0,1000) values and higher LSR values than lesions in the benign group, a finding that had been reported before at 1.5 T [4, 16, [25] [26] [27] [28] . The larger diffusion restriction in malignant lesions is usually attributed to higher cellularity [29] , as there is an inverse correlation between ADC and tumor cellularity [15] . ADC and LSR values, however, may also be affected by the amount of intracellular macromolecular proteins, cell proliferation, extracellular space relative to normal tissue, and by perfusion [15] . In addition, diffusion restriction can be affected by necrosis, abscesses, and thrombi [25] . Thus, the broad overlapping of ADC values in some studies and the varying differentiability between different studies may be caused by differences in group composition. Subgroup analysis in our work provides only little information due to the low case numbers of some subgroups. However, a lower ADC(0,1000) value for squamous cell carcinoma compared to adenocarcinoma was found by tendency, no such tendency was found for LSR. This is in accordance with previous work, in which significantly higher cellularity of squamous cell carcinoma compared to adenocarcinomas was found [15, 30] . In case of ADC determination, values were calculated from at least two b-values and the error of signal intensity due to motion and susceptibility artefacts at each b-values is propagated [26] . Moreover, some benign lesions showed low ADC values similar to malignant lesions [26] . In case of LSR analysis, values reflect a combined effect of diffusion restriction and T2 (and T1) elongation, which intensifies the signal intensity of malignant lesions, but may also occur in some benign situations such as cryptogenic organizing pneumonia [26] . A problem with signal intensity ratios may exist if the standard of reference is inaccurate due to partial volume effects or pathologically changed as in case of inflamed or fatty muscles. To reduce the influence of susceptibility artefacts and partial volume effects, in the presented 3.0 T study small ROIs were used, not including the margin of the lesion or spinal cord. Even if it remains unclear which method is superior for lesion differentiation our results suggest that ADC(0,1000) values provide a significantly better repeatability than LSR values. Thus, for lesion characterization (and therapy monitoring) the ADC(0,1000) determination seems to be superior to the LSR quantification.
The ADC is generally affected by both molecular diffusion and microcirculation effects [31] as shown in an initial study for lung carcinomas [11] . Therefore, reported values vary between different studies, depending on the b-values and acquisition methods used. The use of more than two b-values in DWI allows for separation of tissue diffusivity and blood perfusion effects as proposed by the Intra Voxel Incoherent Motion (IVIM) model [31] . In first studies on pulmonary lesions, IVIM has been applied for differentiation between cancer and obstructive consolidation [11] , and between malignant and benign masses or consolidations [32, 33] . Lower perfusion fractions were found for lung cancer compared to obstructive consolidation [11] and inflammatory lesions [32] , but no differences in perfusion effects were found between malignant and benign masses [33] . In the presented 3.0 T study, in addition to b-values of 0 and 1000 s/mm2, a low b-value of 50s/mm 2 was included in the sequence for a rough assessment of perfusion effects. From the used three b-values it is possible to obtain perfusion sensitive biomarkers as ADC(0, 50) [34] , estimation of perfusion fraction [35] [36] [37] [38] [39] [40] or simply the ADC Diffusion-Weighted Whole-Body MRI difference between the conventionally used ADC(0,1000) and the ADC(50, 1000), which is less affected by perfusion effects, as in the present study. With this simplified IVIM approach, a further separation into perfusion fraction and pseudodiffusion coefficient as obtained for full IVIM approaches is not possible. Perfusion influences were found to be especially large for metastases, followed by adenocarcinoma and benign lesions, whereas they seemed to be low for squamous cell carcinoma. Thus, IVIM analyses seem to provide important data for characterization of pulmonary lesions, which should be investigated further in future studies.
Limitations of the study were the limited number of patients, and that not all patients were examined before treatment. Repeated measurements could not performed in all patients, but sufficient statistical power was reached for the analysis of repeatability between LSR and ADC(0,1000). The results were meaningful and allowed a suggestion for analysis strategy in further studies.
In conclusion, this study indicates the potential of DWIBS at 3.0 T for detecting and characterizing pulmonary lesions. Lesion detection using DWIBS was as good as with FDG PET. For lesion characterization, ADC analysis was superior to signal intensity ratio determination with respect to repeatability. Moreover, an analysis of perfusion influences provides additional information.
